Skip to main content
LIGAND PHARMACEUTICALS INC logo

LIGAND PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · LGND ISIN · US53220K5048 LEI · 5493008K7TB0IKP37H79 US Financial and insurance activities
Open in API
Filings indexed 1,392 across all filing types
Latest filing 2021-05-18 Proxy Solicitation & In…
Country US United States of America
Listing US LGND

About LIGAND PHARMACEUTICALS INC

https://www.ligand.com/

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that functions as a capital and technology partner to the life sciences industry. The company's business model focuses on acquiring and developing royalty-generating assets by investing in the clinical development and commercialization of medicines. It manages a large, diverse portfolio of economic rights to partnered programs across therapeutic areas such as oncology, kidney disease, diabetes, and rare conditions. In addition to its royalty business, Ligand develops and licenses its proprietary technology platforms to a global network of biopharmaceutical partners. Its key technologies include Captisol®, a chemically modified cyclodextrin used to improve the solubility and stability of active pharmaceutical ingredients, and the NITRICIL™ platform.

Recent filings

Filing Released Lang Actions
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is titled as a "Supplemental Materials to the Proxy Statement for the 2021 Annual Meeting of Stockholders" and references a definitive Proxy Statement filed with the SEC. It provides additional details specifically about auditor fees related to the Proxy Statement and the Annual Meeting. The document supplements the Proxy Statement but does not itself contain the Proxy Statement or the full meeting materials. It is clearly a supplement to proxy materials, which fits the category of Proxy Solicitation & Information Statement (PSI). The document is over 5,000 characters and contains detailed information related to proxy solicitation, not just an announcement or a brief note. Therefore, the appropriate classification is PSI with high confidence.
2021-05-18 English
PRIMARY DOCUMENT
Director's Dealing
2021-05-14 English
SC 13G/A
Major Shareholding Notification
2021-05-07 English
10-Q
Interim / Quarterly Report Q1 2021
2021-05-06 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 3, 2021, reporting the issuance of a press release announcing financial results for the quarter ended March 31, 2021. The text explicitly states that the press release is furnished as an exhibit and that the Form 8-K itself is a current report, not the full earnings release. The document length is 3643 characters, which is relatively short and mainly serves as an announcement of the earnings release rather than containing detailed financial data or analysis. According to the rules, such a document is classified as an Earnings Release (ER) because it announces quarterly financial results highlights, even though the full detailed report is in the press release exhibit. The Form 8-K is the standard filing for earnings releases in the US market.
2021-05-03 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a proxy statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. It is labeled as "Definitive Additional Materials" related to a proxy statement for a shareholder meeting. Proxy statements and related materials are used to provide information to shareholders and solicit their votes for matters to be decided at meetings. This fits the category of Proxy Solicitation & Information Statement (PSI). The document length is short (2045 characters) and it is not an announcement of a report but the proxy materials themselves. Therefore, the correct classification is PSI with high confidence.
2021-04-23 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.